: 60 : 11.48
847/2000 provide that a product can be designated as an orphan medicinal product by the European Commission if its sponsor can establish that: (1) the product is intended for the diagnosis, prevention or treatment of a life-threatening or chronically debilitating condition, (2) either (i) such condition affects no more than five in ten thousand persons in the EU when the application is made, or (ii) without the benefits derived from orphan status, it is unlikely that the marketing of the product in the EU would generate sufficient return to justify the necessary investment in its development and (3) there exists no satisfactory method of diagnosis, prevention or treatment of the condition in question that has been authorized in the EU or, if such method exists, the product would be of significant benefit to those affected by that condition
When applied around a herniated disc, TB-500 appears to help seal tears in the outer annulus, preventing further disc material from leaking out
Well create a custom payment plan with a low down payment and monthly payments that fit your budget
Dosing & Reconstitution Guide Reconstitute this 5mg vial with the supplied 3 mL bacteriostatic water (concentration: 1.67 mg/mL)
Mitochondrial dynamics and mitophagy are essential processes that maintain mitochondrial homeostasis and normal physiological functions (Fig
